Notice of Settlement of Derivative Suit

7/23, 9:26 PM (Source: GlobeNewswire)

NEW YORK, July 23, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire P.C. announces the proposed settlement of the derivative action captioned In re Vanda Pharmaceuticals Inc. Derivative Litigation, Case No. 1:19-cv-04293-FB-LB in the United States District Court for the Eastern District of New York.

If you were a stockholder of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) as of July 19, 2021 and continue to own such shares, please click HERE to read the Notice to Current Vanda Stockholders, which contains important information regarding your rights.

Please reach out to counsel for Plaintiffs with any questions or concerns at:

Counsel for Plaintiffs:
Gregory M. Nespole
Daniel Tepper
LEVI & KORSINSKY, LLP
55 Broadway, 10th Floor
New York NY 10006
Fax: (212) 363-7171

W. Scott Holleman
Garam Choe
BRAGAR EAGEL & SQUIRE, P.C.
810 Seventh Avenue, Suite 620
New York, NY 10019
Fax: (212) 486-0462


Primary Logo

Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.